Madher Madher

Dr. Madher Madher

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2015 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
MFMarina Fosso
Marina Fosso
MMMadher Madher
Madher Madher
QZQian Zhang
Qian Zhang
VNVincent de Paul Nzuwah Nziko
Vincent de Paul Nzuwah Nziko
YKYukie Kawasaki
Yukie Kawasaki
CCCheng-Wei Tom Chang
Cheng-Wei Tom Chang

17 April 2018 in MedChemComm
Verified
Journal Article
Closed access
PDF file
YSYagya Subedi
Yagya Subedi
MMMadher Madher
Madher Madher
JTJon Y. Takemoto
Jon Y. Takemoto
CCCheng-Wei Tom Chang
Cheng-Wei Tom Chang
Classical aminoglycoside antibiotics are obsolete or hampered by the emergence of drug resistant bacteria. Recent discoveries of antifungal amphiphilic kanamycins offer new strategies for reviving and repurposing these old drugs. A simple structural modification turns the clinically obsolete antibacterial kanamycin into an antifungal agent. Structure–activity relationship studies have led to the production of K20, an antifungal kanamycin that can be mass-produced for uses in agriculture as well as in animals. This review delineates the path to the discovery of K20 and other related antifungal amphiphilic kanamycins, determination of its mode of action, and findings in greenhouse and field trials with K20 that could lead to crop disease protection strategies.

13 June 2016 in ACS Catalysis
Verified
Journal Article
Closed access
VUVenkatareddy Udumula
Venkatareddy Udumula
SNS. Hadi Nazari
S. Hadi Nazari
SBScott R. Burt
Scott R. Burt
MMMadher Madher
Madher Madher
DMDavid J. Michaelis
David J. Michaelis

18 October 2016 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
QZQian Zhang
Qian Zhang
MMMadher Madher
Madher Madher
JSJaya P. Shrestha
Jaya P. Shrestha
VNVincent de Paul Nzuwah Nziko
Vincent de Paul Nzuwah Nziko
YKYukie Kawasaki
Yukie Kawasaki
CCCheng-Wei Tom Chang
Cheng-Wei Tom Chang

16 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
MMMadher Madher
Madher Madher
YSYagya Subedi
Yagya Subedi
MGMichelle M. Grilley
Michelle M. Grilley
JTJon Y. Takemoto
Jon Y. Takemoto
CCCheng-Wei Tom Chang
Cheng-Wei Tom Chang
Amphiphilic kanamycins derived from the classic antibiotic kanamycin have attracted interest due to their novel bioactivities beyond inhibition of bacteria. In this study, the recently described 4″,6″-diaryl amphiphilic kanamycins reported as inhibitors of connexin were examined for their antifungal activities. Nearly all 4″,6″-diaryl amphiphilic kanamycins tested had antifungal activities comparable to those of 4″,6″-dialkyl amphiphilic kanamycins, reported previously against several fungal strains. The minimal growth inhibitory concentrations (MICs) correlated with the degree of amphiphilicity (cLogD) of the di-substituted amphiphilic kanamycins. Using the fluorogenic dyes, SYTOXTM Green and propidium iodide, the most active compounds at the corresponding MICs or at 2×MICs caused biphasic dye fluorescence increases over time with intact cells. Further lowering the concentrations to half MICs caused first-order dye fluorescence increases. Interestingly, 4×MIC or 8×MIC levels resulted in fluorescence suppression that did not correlate with the MIC and plasma membrane permeabilization. The results show that 4″,6″-diaryl amphiphilic kanamycins are antifungal and that amphiphilicity parameter cLogD is useful for the design of the most membrane-active versions. A cautionary limitation of fluorescence suppression was revealed when using fluorogenic dyes to measure cell-permeation mechanisms with these antifungals at high concentrations. Finally, 4″,6″-diaryl amphiphilic kanamycins elevate the production of cellular reactive oxygen species as other reported amphiphilic kanamycins.